Real-time enrollment status for this epithelial ovarian cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:42 AM UTC
| NCT Number | NCT07218809 |
| Recruiting Status | Recruiting |
| Condition | Epithelial Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,100 participants |
| Active Locations | 17 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 16, 2026 (Jan 16, 2026) |
As of July 13, 2026: Clinical trial NCT07218809 is currently recruiting participants. This clinical trial study for epithelial ovarian cancer is actively seeking new participants at 17 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07218809 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07218809 was last updated Jan 16, 2026 (January 16, 2026). HelloStudys verifies this status automatically.